Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals
Top Cited Papers
- 19 June 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 24 (10), 1527-1535
- https://doi.org/10.1097/qad.0b013e32833a3946
Abstract
Objective: To compare life expectancies between recently diagnosed HIV-infected patients and age and sex-matched uninfected individuals from the general population. Design: National observational HIV cohort in the Netherlands. Methods: Four thousand, six hundred and twelve patients diagnosed with HIV between 1998 and 2007 and still antiretroviral therapy-naive as of 24 weeks after diagnosis were selected. Progression to death compared to the age and sex-matched general population was studied with a multivariate hazards model in 4174 (90.5%) patients without AIDS events at 24 weeks. Life expectancy and number of life years lost were calculated using the predicted survival distribution. Results: During 17 580 person-years of follow-up since 24 weeks after diagnosis [median follow-up 3.3 years, interquartile range (IQR) 1.6–5.8], 118 deaths occurred, yielding a mortality rate of 6.7 [95% confidence interval (CI) 5.5–8.0] per 1000 person-years. Median CD4 cell counts at 24 weeks were 480 cells/μl (IQR 360–650). According to the model, the median number of years lived from age 25 was 52.7 (IQR 44.2–59.3; general population 53.1) for men and 57.8 (49.2–63.7; 58.1) for women without CDC-B event. The number of life years lost varied between 0.4 if diagnosed with HIV at age 25 and 1.4 if diagnosed at age 55; for patients with a CDC-B event this range was 1.8–8.0 years. Conclusion: The life expectancy of asymptomatic HIV-infected patients who are still treatment-naive and have not experienced a CDC-B or C event at 24 weeks after diagnosis approaches that of non-infected individuals. However, follow-up time is short compared to the expected number of years lived.Keywords
This publication has 28 references indexed in Scilit:
- Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated MortalityPLoS Medicine, 2009
- Variable Impact on Mortality of AIDS‐Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS‐Defining Conditions Are Created EqualClinical Infectious Diseases, 2009
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesThe Lancet, 2009
- Use of Risk Equations for Predicting Disease Progression in HIV InfectionClinical Infectious Diseases, 2009
- Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South AfricaAIDS, 2009
- Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research DirectionsClinical Infectious Diseases, 2008
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe Lancet, 2008
- Improved survival in HIV-infected persons: consequences and perspectivesJournal of Antimicrobial Chemotherapy, 2007
- Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studiesAIDS, 2007
- Determinants of survival following HIV-1 seroconversion after the introduction of HAARTThe Lancet, 2003